1. Home
  2. NHI vs TMDX Comparison

NHI vs TMDX Comparison

Compare NHI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Health Investors Inc.

NHI

National Health Investors Inc.

HOLD

Current Price

$78.62

Market Cap

3.7B

Sector

Real Estate

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHI
TMDX
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.9B
IPO Year
1991
2019

Fundamental Metrics

Financial Performance
Metric
NHI
TMDX
Price
$78.62
$136.66
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$84.80
$133.00
AVG Volume (30 Days)
179.5K
835.5K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
4.69%
N/A
EPS Growth
8.88
170.70
EPS
3.17
2.54
Revenue
$357,572,000.00
$566,354,000.00
Revenue This Year
$5.50
$38.84
Revenue Next Year
$11.38
$20.43
P/E Ratio
$24.75
$53.83
Revenue Growth
8.40
41.20
52 Week Low
$65.13
$55.00
52 Week High
$80.56
$156.00

Technical Indicators

Market Signals
Indicator
NHI
TMDX
Relative Strength Index (RSI) 55.21 54.31
Support Level $77.57 $133.50
Resistance Level $79.82 $156.00
Average True Range (ATR) 1.30 8.50
MACD -0.02 0.41
Stochastic Oscillator 36.68 55.98

Price Performance

Historical Comparison
NHI
TMDX

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: